Search results
Found 11499 matches for
Any level of alcohol consumption increases risk of dementia
24 September 2025
Any amount of alcohol consumption may increase risk of dementia, according to the most comprehensive study of alcohol consumption and dementia risk to date.
CanPath awarded $3m to study crises in a changing world
23 September 2025
The Government of Canada has invested in a research platform to track the next pandemic, study the effects of climate change on health, and help explain rising cancer rates in young people.
First direct evidence links gene to fat storage, hinting at new obesity therapies
4 September 2025
A new study, involving researchers at the Big Data Institute, has shown for the first time that a little-known gene, SLTM, plays a direct role in how fat is stored inside human cells. While large population studies had previously linked rare variants in SLTM to higher body mass index (BMI), its function at a cellular level was unknown until now.
Using AI to reclassify multiple sclerosis progression
20 August 2025
Researchers from the Big Data Institute, together with MS experts from ten leading institutions across the world and drug developers from Novartis and Roche, have collaborated to develop an artificial intelligence (AI) model for reclassifying the progression of multiple sclerosis (MS). This model is based on the largest collection of clinical trial data (Novartis-Oxford MS dataset) from people living with MS.
BDI researchers awarded European Research Council Advanced Grants
17 June 2025
Two BDI researchers have been awarded European Research Council Advanced Grants for cutting-edge research.
Genetics Society awards the 2025 Balfour Lecture to Nicky Whiffin
22 November 2024
Professor David Aanensen awarded 2025 Translational Microbiology Prize
7 November 2024
Professor David Aanensen, Principal Investigator at the Pandemic Sciences Institute and Big Data Institute, has been honoured with the 2025 Translational Microbiology Prize in recognition for his work in the areas of translational microbiology and genomic epidemiology.
New GSK collaboration will develop use of biostatistics and AI in research
30 September 2024
With a base in the University's Nuffield Department of Medicine and Department of Statistics, the collaboration will draw upon biostatistical and artificial intelligence (AI) expertise across Oxford, prioritising the development of innovative new tools and methods that translate to medical and biopharmaceutical research.
Researchers develop new approach to document genetic ancestry
6 September 2024